Uppsala Monitoring Centre

Uppsala Monitoring Centre Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation dedicated to safer use of medicines and vaccines.

UMC advances the science of pharmacovigilance and transforms its practice through technological innovation. Uppsala Monitoring Centre (UMC) is a self-funded, mission-driven, non-profit foundation, that works with the World Health Organization and engages stakeholders throughout the global pharmacovigilance community. As a leader in the research and development of new scientific methods, we explore the risks of medicines and vaccines for patients and offer products and services used by health authorities and the pharmaceutical industry worldwide. For more than 40 years, we have provided scientific advancement and operational support to the WHO Programme for International Drug Monitoring.

23/12/2025

Thank you to all our followers for your avid support throughout 2025 and for helping us spread awareness far and wide. Wishing you and those you hold dear a festive and cheerful holiday season.

❄️ from all of us at Uppsala Monitoring Centre!

📖 A recent article published in BMC Infectious Diseases, and part of the CARTA project, explores the factors contributin...
23/12/2025

📖 A recent article published in BMC Infectious Diseases, and part of the CARTA project, explores the factors contributing to incomplete reports of adverse drug reactions in Uganda with a focus on HIV care, specifically dolutegravir-based treatment.

The authors examine patient-based factors, health workforce drivers, and health system restraints that impact data quality, highlighting the need for strengthened pharmacovigilance practices to improve the capture of safety data.

🌐 Read the article at the link below:

Introduction Although dolutegravir (DTG)-based HIV treatment has demonstrated superior efficacy, it has been associated with adverse drug reactions (ADRs). Robust pharmacovigilance systems that ensure that received ADRs reports are complete and accurate facilitate timely regulatory decision making.....

We're   a full stack System Developer to help us develop technology that is instrumental in monitoring the safer use of ...
22/12/2025

We're a full stack System Developer to help us develop technology that is instrumental in monitoring the safer use of medicines and vaccines.

As part of one of UMC's teams, you will use your advanced problem-solving, learning, and innovation skills to perfect code and constantly develop and improve our applications.

Join a creative, inspiring, fun, and collaborative work environment where your ideas will be every bit as valued as your programming expertise.

Submit your application by 7 January 👉 https://ow.ly/7xJQ50XN3Cc

🎉 Congratulations to Elki Sollenbring for 20 years of service to UMC!A pharmacist by training, Elki has worked with seve...
19/12/2025

🎉 Congratulations to Elki Sollenbring for 20 years of service to UMC!

A pharmacist by training, Elki has worked with several teams at UMC over the years, including WHODrug, pharmacovigilance global services, and education and training. She has been a constant force and familiar face to WHO PIDM members around the world, not only developing the pharmacovigilance capacity of programme members but also building lasting relationships across borders and languages.

We are proud to celebrate this career milestone and thank Elki for her professionalism, commitment, and invaluable contributions to the safer use of medicines and vaccines over the years.

💬 What is your favourite memory with Elki? Let us know in the comments below👇

19/12/2025

🌐 Safety systems can be effective without being overly complex. The World Health Organization (WHO) Global Smart Strategy was developed to foster strong, adaptive, and trusted regulatory systems, providing a practical framework to strengthen medicine and vaccine safety systems globally.

In this special episode, recorded during the 43rd Annual Meeting of the WHO PIDM, Shanthi Pal, WHO Pharmacovigilance Team Lead, unpacks the four pillars of the Global Smart PV Strategy and how it can be implemented.

🎧 Listen to today 👉 https://ow.ly/Yrug50XLpiE

𝘉𝘦 𝘴𝘶𝘳𝘦 𝘵𝘰 𝘤𝘩𝘦𝘤𝘬 𝘵𝘩𝘦 𝘴𝘩𝘰𝘸 𝘯𝘰𝘵𝘦𝘴 𝘵𝘰 𝘭𝘦𝘢𝘳𝘯 𝘮𝘰𝘳𝘦 𝘢𝘣𝘰𝘶𝘵 𝘵𝘩𝘦 𝘴𝘵𝘳𝘢𝘵𝘦𝘨𝘺 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘞𝘏𝘖 𝘗𝘐𝘋𝘔.

📻 Namibia's partnership with local radio stations brings   and pharmacovigilance to the nation's ears. By featuring phar...
18/12/2025

📻 Namibia's partnership with local radio stations brings and pharmacovigilance to the nation's ears. By featuring pharmacists and healthcare professionals as guest speakers, they've been able to strengthen their visibility and reinforce their credibility as a reliable source of health information.

Chelsea Möller and Eunice Heitha share how radio helps messaging extend beyond traditional health settings to meet people where they are in the languages they speak.

Read the latest print issue of for more 👉 https://ow.ly/fPnt50XJsih

Two-thirds of pharmacists in Nigeria🇳🇬 witness weekly cough syrup abuse, yet poor reporting systems and unclear guidelin...
17/12/2025

Two-thirds of pharmacists in Nigeria🇳🇬 witness weekly cough syrup abuse, yet poor reporting systems and unclear guidelines prevent effective intervention, leaving youths at risk.

For , Samuel David Chinonyerem details the current landscape and how stricter regulations, enhanced training, and more robust reporting mechanisms may help address medicine misuse.

📖 Read the article at the link below👇

Two-thirds of pharmacists in Nigeria witness weekly cough syrup abuse, yet poor reporting systems and unclear guidelines prevent effective intervention, leaving its youth at risk.

Regional   centres have the power to unite trusted healthcare professionals nationwide. They've played a key role in the...
16/12/2025

Regional centres have the power to unite trusted healthcare professionals nationwide. They've played a key role in the success of Iraq's campaigns, rallying hundreds of trained PV officers with immediate access to local communities across the country.

Ban Al-Shimran, Ahmed Sami, and Manal Younus share their tips for collaborating with regional centres to build lasting PV partnerships in 👉 https://ow.ly/fPnt50XJsih

Monitoring adverse events following immunisation (AEFI) is essential for vaccine and patient safety.South Africa🇿🇦 conti...
16/12/2025

Monitoring adverse events following immunisation (AEFI) is essential for vaccine and patient safety.

South Africa🇿🇦 continues to strengthen their vaccine safety surveillance and pharmacovigilance systems thanks to recent and training. Alongside World Health Organization (WHO), Sahpra, and National Department of Health (South Africa) colleagues, UMC facilitated a 3-day training to equip national and provincial EPI staff on AEFI data management and capacity building.

Thanks to our co-facilitators and participants for a fruitful workshop!

Looking for more? Read up on how VigiFlow keeps the wheels of turning in 👉 https://ow.ly/m0Bh50XKbYh

This year's ISoP Online Annual Meeting brought together over 500 attendees from 80+ countries to explore the evolution a...
15/12/2025

This year's ISoP Online Annual Meeting brought together over 500 attendees from 80+ countries to explore the evolution and future of . Over four days, a multidisciplinary group of PV professionals participated in high-level discussions, hands-on workshops, and networking activities, all of which set an inspiring tone for the future of medicines and patient safety worldwide.

Christina Saad, Amira Onsy Shehata, and Mohamed A. Elhawary share some of their favourite moments from ISoP 2025 Cairo in .

📖 Read their article at the link below👇

Over 500 attendees from 80+ countries met in Cairo at ISoP 2025, reflecting on pharmacovigilance progress and shaping strategies for its future.

Join ISoP Online, speakers, and attendees for the ISoP European   Seminar in Basel, Switzerland🇨🇭The first European edit...
12/12/2025

Join ISoP Online, speakers, and attendees for the ISoP European Seminar in Basel, Switzerland🇨🇭

The first European edition of the artificial intelligence seminar will explore how to keep humans in the loop when it comes to AI-powered .

More details about in the post below👇

📢 Registration is open for the 1st ISoP European Artificial Intelligence Seminar 2026!

📍 16–17 February 2026 | Basel, Switzerland

💡 Theme: AI-Powered Pharmacovigilance: Humans in the Loop

Join us for two days of insightful discussions, practical case studies, and forward-looking perspectives on how AI and human expertise can work together to advance medicines safety.

🔗 Register now:

https://isoponline.org/training/seminar/isop-seminar-basel-2026-registration/

We look forward to welcoming you to Basel!

  has been lighting up TV screens in Montenegro🇲🇪 since 2019. Thanks to a proactive approach,   staff have been frequent...
11/12/2025

has been lighting up TV screens in Montenegro🇲🇪 since 2019. Thanks to a proactive approach, staff have been frequent guests in TV studios each year, educating the public and raising awareness on the safe use of medicines, all while building trust and sustained cooperation with the media.

Veselinka Vukicevic tells us more in the latest print edition of 👉 https://ow.ly/wm6850XBInr

Institut za ljekove i medicinska sredstva Crne Gore

Adress

Bredgränd 7
Uppsala
75320

Öppettider

Måndag 09:00 - 17:00
Tisdag 09:00 - 17:00
Onsdag 09:00 - 17:00
Torsdag 09:00 - 17:00
Fredag 09:00 - 17:00

Telefon

+4618656060

Aviseringar

Var den första att veta och låt oss skicka ett mail när Uppsala Monitoring Centre postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Dela

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Inspire. Engage. Transform.

Uppsala Monitoring Centre (UMC) advances the science of pharmacovigilance and inspires patient safety initiatives all over the world. As an independent, non-profit foundation, we engage stakeholders who share our vision and collaborate to build a global patient safety culture. As a leader in the research and development of new scientific methods, we explore the benefits and risks of medicines to help minimise harm to patients, and offer products and services used by health authorities and life-science companies worldwide.

Our unique expertise makes us an organisation with the capacity to transform patient safety from an ambition into a reality. For more than 40 years, we have provided scientific leadership and operational support to the WHO Programme for International Drug Monitoring, expanding the global pharmacovigilance network to reach more than 95% of the world’s population.